Citation Impact
Citing Papers
Outcomes After Stereotactic Body Radiotherapy or Radiofrequency Ablation for Hepatocellular Carcinoma
2015
Global Cancer Incidence and Mortality Rates and Trends—An Update
2015 Standout
Antiemetics: American Society of Clinical Oncology Clinical Practice Guideline Update
2011 Standout
2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer
2015 Standout
Recent developments in esophageal adenocarcinoma
2013
Phase Ib study evaluating a self-adjuvanted mRNA cancer vaccine (RNActive®) combined with local radiation as consolidation and maintenance treatment for patients with stage IV non-small cell lung cancer
2014
Comprehensive analyses of tumor immunity: implications for cancer immunotherapy
2016 Standout
Acute Biological Effects of Simulating the Whole-Body Radiation Dose Distribution from a Solar Particle Event Using a Porcine Model
2011 StandoutNobel
Head and neck squamous cell carcinoma
2020 Standout
Clinical impact of dosimetry quality assurance programmes assessed by radiobiological modelling of data from the thermoluminescent dosimetry study of the European Organization for Research and Treatment of Cancer
2000
Ataxia‐telangiectasia, cancer and the pathobiology of the ATM gene
1999
Management of early-stage non-small cell lung cancer using stereotactic ablative radiotherapy: Controversies, insights, and changing horizons
2014
Perspectives on cancer therapy-induced mucosal injury
2004 Standout
mRNA vaccines — a new era in vaccinology
2018 StandoutNobel
Cell cycle checkpoint signaling through the ATM and ATR kinases
2001 Standout
Role of Transforming Growth Factor β in Human Disease
2000 Standout
Almost all articles on cancer prognostic markers report statistically significant results
2007
Improving target delineation on 4-dimensional CT scans in stage I NSCLC using a deformable registration tool
2010
Associations of Radiomic Data Extracted from Static and Respiratory-Gated CT Scans with Disease Recurrence in Lung Cancer Patients Treated with SBRT
2017
Guidelines on the radical management of patients with lung cancer
2010
Lymphocyte radiosensitivity correlated with pelvic radiotherapy morbidity
2003
The biology and management of non-small cell lung cancer
2018 StandoutNature
ERS/ESTS clinical guidelines on fitness for radical therapy in lung cancer patients (surgery and chemo-radiotherapy)
2009 Standout
Stereotactic Body Radiation Therapy for Early-Stage Non–Small-Cell Lung Carcinoma: Four-Year Results of a Prospective Phase II Study
2009
The DNA Damage Response Kinases DNA-dependent Protein Kinase (DNA-PK) and Ataxia Telangiectasia Mutated (ATM) Are Stimulated by Bulky Adduct-containing DNA
2011 StandoutNobel
Outcomes of Stereotactic Ablative Radiotherapy in Patients With Potentially Operable Stage I Non-Small Cell Lung Cancer
2011
Metastatic non-small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2016 Standout
Clinical correlations between late normal tissue endpoints after radiotherapy: Implications for predictive assays of radiosensitivity
1993
Genetics and genomics of radiotherapy toxicity: towards prediction
2011
Stereotactic Body Radiation Therapy for Inoperable Early Stage Lung Cancer
2010 Standout
Radiotherapy-induced nausea and vomiting (RINV): antiemetic guidelines
2004
Prediction of clonogenic cell survival curves based on the number of residual DNA double strand breaks measured by γH2AX staining
2009
Stereotactic body radiation therapy: a novel treatment modality
2009
A Technique of Partial Breast Irradiation Utilizing Proton Beam Radiotherapy: Comparison with Conformal X-Ray Therapy
2007
Inter-strain variance in late phase of erythematous reaction or leg contracture after local irradiation among three strains of mice
2005
Radiomics: Images Are More than Pictures, They Are Data
2015 Standout
Evidence for a Positive Correlation betweenin VitroRadiosensitivity of Normal Human Skin Fibroblasts and the Occurrence of Subcutaneous Fibrosis after Radiotherapy
1994
The radiation-induced fibroatrophic process: therapeutic perspective via the antioxidant pathway
2004
Predicting outcomes in radiation oncology—multifactorial decision support systems
2012
Prospective comparison of in vitro normal cell radiosensitivity and normal tissue reactions in radiotherapy patients
1993
Treatment-time-dependence models of early and delayed radiation injury in rat small intestine
2000
Hepatocellular carcinoma
2021 Standout
Natural History of Stage I Non-Small Cell Lung Cancer
2007
Low predictive value of intrinsic fibroblast radiosensitivity for fibrosis development following radiotherapy for breast cancer
1998
Differentiation state of skin fibroblast cultures versus risk of subcutaneous fibrosis after radiotherapy
1998
A stress response pathway regulates DNA damage through β2-adrenoreceptors and β-arrestin-1
2011 StandoutNatureNobel
CT-based radiomic analysis of stereotactic body radiation therapy patients with lung cancer
2016
Machine Learning methods for Quantitative Radiomic Biomarkers
2015 Standout
Bevacizumab plus Radiotherapy–Temozolomide for Newly Diagnosed Glioblastoma
2014 Standout
Severe radiation pneumonitis after lung stereotactic ablative radiation therapy in patients with interstitial lung disease
2016
Do Pressures to Publish Increase Scientists' Bias? An Empirical Support from US States Data
2010 Standout
Lung cancer: current therapies and new targeted treatments
2016 Standout
Early-stage lung cancer in elderly patients: A population-based study of changes in treatment patterns and survival in the Netherlands
2012
Preventing or reducing late side effects of radiation therapy: radiobiology meets molecular pathology
2006 Standout
Breathing new life into immunotherapy: review of melanoma, lung and kidney cancer
2013
The Inherited Basis of Human Radiosensitivity
2001
Influence of connective tissue diseases on the expression of radiation side effects: A systematic review
2006
Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2017 Standout
Potential clinical impact of normal-tissue intrinsic radiosensitivity testing
1997
Outcomes of Risk-Adapted Fractionated Stereotactic Radiotherapy for Stage I Non–Small-Cell Lung Cancer
2008
The pathobiology of mucositis
2004 Standout
Chemotherapy-Induced Nausea and Vomiting
2008 Standout
Fluoroscopically Guided Interventional Procedures: A Review of Radiation Effects on Patients’ Skin and Hair
2010
Patterns of Disease Recurrence after SABR for Early Stage Non–Small-Cell Lung Cancer: Optimizing Follow-Up Schedules for Salvage Therapy
2015
Patterns of disease recurrence after stereotactic ablative radiotherapy for early stage non-small-cell lung cancer: a retrospective analysis
2012
Absence of mutations in the ATM gene in breast cancer patients with severe responses to radiotherapy
1997
Guidelines for the management of oesophageal and gastric cancer
2011
γH2AX and cancer
2008
Differential radiosensitising effect of the scid mutation among tissues, studied using high and low dose rates: implications for prognostic indicators in radiotherapy
1994
Radiation‐induced oral mucositis in mice: strain differences
2002
The influence of pre‐radiation salivary flow rates and radiation dose on parotid salivary gland dysfunction in patients receiving radiotherapy for head and neck cancers
1998
Genetic and epigenetic features in radiation sensitivity
2005
Safety and Efficacy of Bevacizumab With Hypofractionated Stereotactic Irradiation for Recurrent Malignant Gliomas
2009
Lung-cancer related chest events detected by periodical follow-up CT after stereotactic body radiotherapy for stage I primary lung cancer: retrospective analysis of incidence of lung-cancer related chest events and outcomes of salvage treatment
2012
Validation of High-Risk Computed Tomography Features for Detection of Local Recurrence After Stereotactic Body Radiation Therapy for Early-Stage Non-Small Cell Lung Cancer
2016
Tumor-associated neutrophils and macrophages in non-small cell lung cancer: No immediate impact on patient outcome
2013
Percutaneous radiofrequency ablation for clinical stage I non–small cell lung cancer: Results in 20 nonsurgical candidates
2007
Cytokinesis-block micronucleus cytome assay
2007 Standout
Can risk of radiotherapy-induced normal tissue complications be predicted from genetic profiles?
2005
Gastric cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2010 Standout
TGF-?1 levels in pre-treatment plasma identify breast cancer patients at risk of developing post-radiotherapy fibrosis
1999
Neutrophils in cancer: neutral no more
2016 Standout
Rib fracture after stereotactic radiotherapy for primary lung cancer: prevalence, degree of clinical symptoms, and risk factors
2013
Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): a phase 3 multicentre randomised controlled trial
2011 Standout
Cellular radiosensitivity and complication risk after curative radiotherapy
2000
A practical approach to pulmonary risk assessment in the radiotherapy of lung cancer
2004
British Thoracic Society guidelines for the investigation and management of pulmonary nodules: accredited by NICE
2015
The radiotherapeutic injury – a complex ‘wound’
2002
Hepatitis B virus induces RNR-R2 expression via DNA damage response activation
2015 StandoutNobel
Metastatic non-small cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2018 Standout
Artificial intelligence in radiology
2018 Standout
Decoding tumour phenotype by noninvasive imaging using a quantitative radiomics approach
2014 Standout
The DAHANCA 6 randomized trial: Effect of 6 vs 5 weekly fractions of radiotherapy in patients with glottic squamous cell carcinoma
2015
Universal Survival Curve and Single Fraction Equivalent Dose: Useful Tools in Understanding Potency of Ablative Radiotherapy
2008
Radiomics: the bridge between medical imaging and personalized medicine
2017 Standout
The North American Experience with Stereotactic Body Radiation Therapy in Non-small Cell Lung Cancer
2007
Comparison of particle beam therapy and stereotactic body radiotherapy for early stage non-small cell lung cancer: A systematic review and hypothesis-generating meta-analysis
2017
Prophylaxe und Therapie akuter Strahlenfolgen an Haut und Schleimhaut
1998
Hepatocellular carcinoma
2022 Standout
Evidence-based recommendations for the use of antiemetics in radiotherapy
2005
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease
2012 Standout
European Organisation for Research and Treatment of Cancer Recommendations for Planning and Delivery of High-Dose, High-Precision Radiotherapy for Lung Cancer
2010
Stereotactic ablative radiotherapy: A potentially curable approach to early stage multiple primary lung cancer
2013
Patient-to-Patient Variability in the Expression of Radiation-Induced Normal Tissue Injury.
1994
Timing and duration of 5-HT3 receptor antagonist therapy for the prophylaxis of radiotherapy-induced nausea and vomiting: a systematic review of randomized and non-randomized studies
2012
DNA Topoisomerase I Inhibitors: Chemistry, Biology, and Interfacial Inhibition
2009 Standout
ICRP PUBLICATION 118: ICRP Statement on Tissue Reactions and Early and Late Effects of Radiation in Normal Tissues and Organs — Threshold Doses for Tissue Reactions in a Radiation Protection Context
2012 Standout
Current trends on ICT technologies for enterprise information systems
2015
Industry 4.0 technologies: Implementation patterns in manufacturing companies
2019 Standout
Stereotactic Body Radiation Therapy in Multiple Organ Sites
2007
Multi-Institutional Phase I/II Trial of Stereotactic Body Radiation Therapy for Lung Metastases
2009 Standout
Nanotechnology for Multimodal Synergistic Cancer Therapy
2017 Standout
Dexamethasone for the Prophylaxis of Radiation-Induced Emesis: A National Cancer Institute of Canada Clinical Trials Group Phase III Study
2000
Recommendations for the Use of Antiemetics: Evidence-Based, Clinical Practice Guidelines
1999
American Society of Clinical Oncology Guideline for Antiemetics in Oncology: Update 2006
2006
Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases
2018 Standout
Association between Polymorphisms in the DNA Repair Genes, XRCC1, APE1, and XPD and Acute Side Effects of Radiotherapy in Breast Cancer Patients
2005
New Strategies in Lung Cancer: Translating Immunotherapy into Clinical Practice
2014
Technical report: The use of cryopreserved lymphocytes in assessing inter-individual radiosensitivity with the micronucleus assay
2000
Emergence of Stereotactic Body Radiation Therapy and Its Impact on Current and Future Clinical Practice
2014
Ionizing Radiation Selectively Reduces Skin Regulatory T Cells and Alters Immune Function
2014 StandoutNobel
Intrinsic radiosensitivity of healthy donors and cancer patients as determined by the lymphocyte micronucleus assay
1997
Deterministic rather than stochastic factors explain most of the variation in the expression of skin telangiectasia after radiotherapy
2002
5-Hydroxytryptamine-3 Receptor Antagonist With or Without Short-Course Dexamethasone in the Prophylaxis of Radiation Induced Emesis: A Placebo-Controlled Randomized Trial of the National Cancer Institute of Canada Clinical Trials Group (SC19)
2006
Global cancer statistics, 2012
2015 Standout
Patient-to-patient variability in the expression of radiation-induced normal tissue injury
1994
The Oral Neurokinin-1 Antagonist Aprepitant for the Prevention of Chemotherapy-Induced Nausea and Vomiting: A Multinational, Randomized, Double-Blind, Placebo-Controlled Trial in Patients Receiving High-Dose Cisplatin—The Aprepitant Protocol 052 Study Group
2003 Standout
American Society of Clinical Oncology Treatment of Unresectable Non–Small-Cell Lung Cancer Guideline: Update 2003
2003 Standout
Integrating mechanisms of pulmonary fibrosis
2011 Standout
In vitro differentiation characteristics of human skin fibroblasts: correlations with radiotherapy-induced breast fibrosis in patients
2000
Works of Jan Nyman being referenced
A randomised placebo controlled study with ondansetron in patients undergoing fractionated radiotherapy
1996
Fibroblast radiosensitivity versus acute and late normal skin responses in patients treated for breast cancer
1995
Prognostic factors for acute and late skin reactions in radiotheraphy patients
1996
Retrospective Cohort Study of Bronchial Doses and Radiation-Induced Atelectasis After Stereotactic Body Radiation Therapy of Lung Tumors Located Close to the Bronchial Tree
2013
Health economic evaluation of stent or endoluminal brachytherapy as a palliative strategy in patients with incurable cancer of the oesophagus or gastro-oesophageal junction: results of a randomized clinical trial
2005
Stereotactic hypofractionated radiotherapy for stage I non-small cell lung cancer—Mature results for medically inoperable patients
2005
Factors important for efficacy of stereotactic body radiotherapy of medically inoperable stage I lung cancer. A retrospective analysis of patients treated in the Nordic countries
2006
Prediction of normal-tissue tolerance to radiotherapy from in-vitro cellular radiation sensitivity
1992
Mature results from a Swedish comparison study of conventional versus accelerated radiotherapy in head and neck squamous cell carcinoma – The ARTSCAN trial
2015
Stereotactic body radiotherapy for medically inoperable patients with stage I non-small cell lung cancer – A first report of toxicity related to COPD/CVD in a non-randomized prospective phase II study
2008
Combined stent insertion and single high-dose brachytherapy in patients with advanced esophageal cancer - results of a prospective safety study
2011
Radiation-induced rib fractures after hypofractionated stereotactic body radiation therapy of non-small cell lung cancer: A dose– and volume–response analysis
2009
DNA double strand break quantification in skin biopsies
2004
Prognostic Factors for Local Control and Survival of Cancer of the Oral Tongue a retrospective analysis of 230 cases in Western Sweden
1993
Swedish lung cancer radiation study group: the prognostic value of anaemia, thrombocytosis and leukocytosis at time of diagnosis in patients with non-small cell lung cancer
2012
SPACE – A randomized study of SBRT vs conventional fractionated radiotherapy in medically inoperable stage I NSCLC
2016
Normal tissue radiosensitivity — How important is it?
1996
Changes in the Basal Cell Density in Pig Skin After Single Radiation Doses with Different Dose Rates
1991
Describing patients' normal tissue reactions: Concerning the possibility of individualising radiotherapy dose prescriptions based on potential predictive assays of normal tissue radiosensitivity
1998
Time factor for acute tissue reactions following fractionated irradiation: a balance between repopulation and enhanced radiosensitivity
2003
The relationship between cellular radiation sensitivity and tissue response may provide the basis for individualising radiotherapy schedules
1994
Accelerated Hyperfractionated Radiotherapy Combined with Induction and Concomitant Chemotherapy for Inoperable Non-small-cell Lung Cancer: Impact of Total Treatment Time
1998
Long-term results of a prospective phase II trial of medically inoperable stage I NSCLC treated with SBRT – the Nordic experience
2015
START: A phase III study of L-BLP25 cancer immunotherapy for unresectable stage III non-small cell lung cancer.
2013
Sustainable PLM through Intelligent Products
2012
OC-0565: SPACE - A randomized study of SBRT vs conventional fractionated radiotherapy in medically inoperable stage I NSCLC
2014
Outcome in a Prospective Phase II Trial of Medically Inoperable Stage I Non–Small-Cell Lung Cancer Patients Treated With Stereotactic Body Radiotherapy
2009